Pharmaceutical manufacturing

This image provided by Sarepta Therapeutics in December 2019 shows a box and vial of their drug Vyondys 53. On Thursday, Dec. 12, 2019, U.S. health regulators said they approved this second drug for a debilitating form of muscular dystrophy, a surprise decision after the medication was rejected for safety concerns just four months earlier. (Sarepta Therapeutics via AP)
December 13, 2019 - 1:28 pm
WASHINGTON (AP) — U.S. health regulators approved a second drug for a debilitating form of muscular dystrophy, a surprise decision after the medication was rejected for safety concerns just four months ago. The ruling marks the second time the Food and Drug Administration has granted preliminary...
Read More
December 06, 2019 - 8:10 pm
WASHINGTON (AP) — A bipartisan Senate bill to curb prescription drug costs for Medicare recipients got a makeover Friday to lower copays and make it easier for seniors to budget for their expenses. The updated legislation unveiled by Sens. Chuck Grassley, R-Iowa, and Ron Wyden, D-Ore., would lower...
Read More
November 21, 2019 - 7:59 pm
HONOLULU (AP) — Agrochemicals company Monsanto is pleading guilty to spraying a banned pesticide on its Maui fields in 2014. Monsanto, now owned by pharmaceutical company Bayer, is also agreeing to pay $10 million in an agreement over charges it unlawfully stored acute hazardous waste. The money...
Read More
FILE - In this Nov. 8, 2018 file photo, the U.S. Medicare Handbook is photographed in Washington. Medicare’s new prescription drug plan finder has a glitch that can steer unwitting seniors to coverage that costs much more than they need to pay. (AP Photo/Pablo Martinez Monsivais)
November 21, 2019 - 4:06 pm
WASHINGTON (AP) — Medicare’s revamped prescription plan finder can steer unwitting seniors to coverage that costs much more than they need to pay, according to people who help with sign-ups as well as program experts. Serving some 60 million Medicare recipients, the plan finder is the most commonly...
Read More
FILE - In this June 15, 2018, file photo, pharmaceuticals are seen in North Andover, Mass. Feeling a new urgency as the impeachment probe advances, the White House is ramping up its push to get a bill through Congress that curbs prescription drug costs. President Donald Trump’s top domestic policy adviser says the effort has advanced beyond anything seen in years even as he acknowledges the “current complications.” (AP Photo/Elise Amendola, file)
November 18, 2019 - 2:22 am
WASHINGTON (AP) — The White House is ramping up its push to get a bill through Congress that curbs prescription drug costs, feeling a new urgency as the impeachment investigation advances amid the 2020 election campaign. The effort has progressed beyond anything seen in years, says President Donald...
Read More
Edward McCarthy, center, works with fellow traders on the floor of the New York Stock Exchange, Tuesday, Oct. 29, 2019. Stocks are off to a slightly lower start on Wall Street as communications and energy companies fall. (AP Photo/Richard Drew)
October 29, 2019 - 4:53 pm
Technology companies led stocks lower on Wall Street Tuesday as a wobbly day of trading ended with modest losses for the market. Health care stocks jumped on stronger-than-expected reports from drugmakers, but losses by internet and media companies held the market in check. Companies have largely...
Read More
FILE - In this April 26, 2019, file photo, RELPAX migraine pills manufactured by Pfizer are arranged for a photo in Doral, Fla. Pfizer Inc. reports financial earns Tuesday, Oct. 29. (AP Photo/Wilfredo Lee, File)
October 29, 2019 - 7:07 am
Pfizer's third-quarter profit nearly doubled after it booked a $8.1 billion gain on the creation of a consumer health products joint venture, part the drugmaker's plan to narrow its focus on cancer treatments and other innovative medicines. The New York company's profit handily beat Wall Street...
Read More
FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports financial earns Tuesday, Oct. 29, 2019. (AP Photo/Seth Wenig, File)
October 29, 2019 - 6:47 am
Big jumps in sales of Merck's top two blockbuster drugs drove revenue up 15%, but higher spending across the board pushed profits down 3% in the third quarter. Merck still easily beat Wall Street forecasts and boosted its forecast for the year. The quarter were dominated again by advanced cancer...
Read More
Trader Craig Esposito works on the floor of the New York Stock Exchange, Monday, Oct. 28, 2019. The S&P 500 rose 16 points, or 0.6 %, to 3,039, while the Dow Jones Industrial Average added 132 points, or 0.5%, to 27,090. (AP Photo/Richard Drew)
October 28, 2019 - 4:29 pm
The S&P 500 index closed at an all-time high Monday, extending a recent string of gains in what's mostly been a solid month for the market. The benchmark index closed at 3,039.42, around 14 points above its previous record set on July 26. The S&P 500 notched its latest milestone after weeks...
Read More
FILE - In this Oct. 2, 2019, file photo specialists James Denaro, left, and Mario Picone work on the floor of the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EDT on Friday, Oct. 25. (AP Photo/Richard Drew, File)
October 25, 2019 - 4:51 pm
The S&P 500 closed just short of an all-time high Friday as investors welcomed solid company earnings reports and an encouraging update on trade talks between the U.S. and China. Technology, communications services and financial stocks powered the rally. The index ended within 0.1% of its...
Read More

Pages